
Creative Medical Technology Holdings, Inc.
$2.18
-0.0550 (-2.47%)
Latest News
Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
Feb 10, 2026 09:00 AM
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
Jan 13, 2026 09:15 AM
Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
Jan 06, 2026 09:15 AM
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
Dec 17, 2025 09:15 AM
Creative Medical Technology Holdings Announces World Health Organization Approval of "olastrocel" as INN for Lead Allogeneic Cell Therapy CELZ-201
Dec 02, 2025 09:15 AM
Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits
Oct 30, 2025 09:15 AM
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
Oct 29, 2025 09:00 AM
Creative Medical Technology Holdings Issues Letter to Shareholders
Oct 27, 2025 08:15 AM
Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs
Oct 07, 2025 09:15 AM
Sign Up For CELZ Email News Alerts
Disclosure
RedChip Companies, Inc. research reports, company profiles, and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that RedChip Companies Inc. is an investor relations firm hired by certain companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles, or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the Ontario Securities Commission (“OSC”) at www.osc.gov.on.ca.
Creative Medical Technology (CELZ) is a client of RedChip Companies. CELZ agreed to pay RedChip Companies, Inc. a $10,000 monthly cash fee, beginning in July 2025, for six month of investor awareness services. CELZ also agreed to pay RedChip a one-time $45,000 fee for a national TV ad campaign aired weekdays from October 8 to October 29, 2024, a one-time $60,000 fee for a national TV ad campaign aired weekdays from January 27 to February 14, 2025, a one-time $75,000 fee for a 10-day national TV ad campaign aired weekdays in August 2025, a one-time $100,000 fee for a 10-day national TV ad campaign aired October 21 to November 3, 2025, and a one-time $25,000 fee for a 5-day national TV ad campaign aired January 8 to January 14, 2026.
Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. RedChip investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services.